Shinpoong Pharmaceutical Co.,Ltd (KRX:019175)
25,750
+850 (3.41%)
Last updated: Nov 26, 2025, 9:00 AM KST
KRX:019175 Revenue
Shinpoong Pharmaceutical Co.,Ltd had revenue of 62.61B KRW in the quarter ending September 30, 2025, with 12.21% growth. This brings the company's revenue in the last twelve months to 231.90B, up 7.64% year-over-year. In the year 2024, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 221.09B with 10.42% growth.
Revenue (ttm)
231.90B
Revenue Growth
+7.64%
P/S Ratio
3.36
Revenue / Employee
286.65M
Employees
809
Market Cap
778.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 221.09B | 20.87B | 10.42% |
| Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
| Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
| Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
| Dec 31, 2020 | 197.75B | 8.03B | 4.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.50T |
| Celltrion | 3.90T |
| Yuhan | 2.14T |
| Hanmi Pharm. | 1.47T |
| SK Biopharmaceuticals | 675.41B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |